Lima Alexandre, van Genderen Michel E, van Bommel Jasper, Klijn Eva, Jansem Tim, Bakker Jan
Crit Care. 2014 Jun 19;18(3):R126. doi: 10.1186/cc13932.
Recent clinical studies have shown a relationship between abnormalities in peripheral perfusion and unfavorable outcome in patients with circulatory shock. Nitroglycerin is effective in restoring alterations in microcirculatory blood flow. The aim of this study was to investigate whether nitroglycerin could correct the parameters of abnormal peripheral circulation in resuscitated circulatory shock patients.
This interventional study recruited patients who had circulatory shock and who persisted with abnormal peripheral perfusion despite normalization of global hemodynamic parameters. Nitroglycerin started at 2 mg/hour and doubled stepwise (4, 8, and 16 mg/hour) each 15 minutes until an improvement in peripheral perfusion was observed. Peripheral circulation parameters included capillary refill time (CRT), skin-temperature gradient (Tskin-diff), perfusion index (PI), and tissue oxygen saturation (StO2) during a reactive hyperemia test (RincStO2). Measurements were performed before, at the maximum dose, and after cessation of nitroglycerin infusion. Data were analyzed by using linear model for repeated measurements and are presented as mean (standard error).
Of the 15 patients included, four patients (27%) responded with an initial nitroglycerin dose of 2 mg/hour. In all patients, nitroglycerin infusion resulted in significant changes in CRT, Tskin-diff, and PI toward normal at the maximum dose of nitroglycerin: from 9.4 (0.6) seconds to 4.8 (0.3) seconds (P < 0.05), from 3.3 °C (0.7 °C) to 0.7 °C (0.6 °C) (P < 0.05), and from [log] -0.5% (0.2%) to 0.7% (0.1%) (P < 0.05), respectively. Similar changes in StO2 and RincStO2 were observed: from 75% (3.4%) to 84% (2.7%) (P < 0.05) and 1.9%/second (0.08%/second) to 2.8%/second (0.05%/second) (P < 0.05), respectively. The magnitude of changes in StO2 was more pronounced for StO2 of less than 75%: 11% versus 4%, respectively (P < 0.05).
Dose-dependent infusion of nitroglycerin reverted abnormal peripheral perfusion and poor tissue oxygenation in patients following circulatory shock resuscitation. Individual requirements of nitroglycerin dose to improve peripheral circulation vary between patients. A simple and fast physical examination of peripheral circulation at the bedside can be used to titrate nitroglycerin infusion.
近期临床研究表明,外周灌注异常与循环性休克患者的不良预后之间存在关联。硝酸甘油可有效恢复微循环血流改变。本研究旨在探讨硝酸甘油是否能纠正复苏后循环性休克患者外周循环异常的参数。
本干预性研究招募了患有循环性休克且尽管整体血流动力学参数已恢复正常但外周灌注仍异常的患者。硝酸甘油起始剂量为2毫克/小时,每15分钟逐步加倍(4、8和16毫克/小时),直至观察到外周灌注改善。外周循环参数包括毛细血管再充盈时间(CRT)、皮肤温度梯度(Tskin - diff)、灌注指数(PI)以及反应性充血试验(RincStO2)期间的组织氧饱和度(StO2)。在硝酸甘油输注前、最大剂量时以及停止输注后进行测量。数据采用重复测量线性模型进行分析,并以均值(标准误差)表示。
纳入的15例患者中,4例患者(27%)在初始硝酸甘油剂量为2毫克/小时时出现反应。在所有患者中,硝酸甘油输注在最大剂量时使CRT、Tskin - diff和PI显著向正常变化:从9.4(0.6)秒变为4.8(0.3)秒(P < 0.05),从3.3°C(0.7°C)变为0.7°C(0.6°C)(P < 0.05),以及从[log] - 0.5%(0.2%)变为0.7%(0.1%)(P < 0.05)。在StO2和RincStO2中也观察到类似变化:分别从75%(3.4%)变为84%(2.7%)(P < 0.05)以及从1.9%/秒(0.08%/秒)变为2.8%/秒(0.05%/秒)(P < 0.05)。对于低于75%的StO2,其变化幅度更为明显:分别为11%和4%(P < 0.05)。
剂量依赖性输注硝酸甘油可逆转循环性休克复苏后患者的外周灌注异常和组织氧合不良。不同患者改善外周循环所需的硝酸甘油剂量个体差异较大。床边简单快速的外周循环体格检查可用于调整硝酸甘油输注剂量。